Maintenance and Frontline Therapy in CLL

(5:26)

Frontline Therapy

(31:32)

Frontline Therapy in Melanoma

(3:50)

Copy of Dr. McCollum on Frontline Therapy for Patients With Metastatic CRC

(13)

Dr. Hong on Moving Tisotumab Vedotin to Frontline Therapy for Cervical Cancer

(54)

Unresectable HCC: Considerations for Resection and Frontline Therapy

(3:50)

Frontline Therapy for Polycythemia Vera

(5:54)

Frontline Therapy for mCRC

(8:42)

How frontline therapy impacts the management of patients with ALL prior to CAR-T

(1:9)

Advances in Frontline Therapy for CLL

(4:42)

Frontline therapy for multiple myeloma

(1:27)

Choosing Frontline Therapy for Mantle Cell Lymphoma

(5:42)

NALIRIFOX as frontline therapy for PDAC

(1:28)

Frontline Therapy Project

(30:55)

Tian Zhang on Frontline Therapy in RCC

(1:49)

First-Line or Frontline Therapy Options In Multiple Myeloma | 2023 IMF Patient and Family Seminar

(57:52)

Frontline Therapy Options for Stage IV Ovarian Cancer

(3:34)

Ibrutinib’s Role as Frontline Therapy in CLL

(6:3)

Selecting the Optimal Frontline Therapy in CLL

(4:20)

Dr. Wierda on Frontline Therapy for Older CLL Patients Compared to Younger

(2:13)